dactinomycin has been researched along with Cholera Infantum in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bell, FW; Goulland, EL; Hayden, DW; Khanna, C; Klausner, JS; Lund, EM; Redic, KA | 1 |
| Amato, RJ; Daliani, D; Do, KA; Finn, L; Fizazi, K; Kim, J; Logothetis, CJ; Millikan, RE; Pagliaro, LC; Papandreou, CN; Prow, DM; Tu, SM; Wang, X | 1 |
| Evans, RA; Somerville, PJ | 1 |
| Cham, W; D'Angio, GJ; Exelby, P; Ghavimi, G; Jereb, B; Lattin, PB; Marcove, R; Murphy, ML; Rosen, G; Tefft, M | 1 |
| Baker, LH; Cummings, G; Haas, CD; Samson, MK | 1 |
| Floersheim, GL | 1 |
2 trial(s) available for dactinomycin and Cholera Infantum
| Article | Year |
|---|---|
Randomized controlled trial of doxorubicin versus dactinomycin in a multiagent protocol for treatment of dogs with malignant lymphoma.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Dactinomycin; Dog Diseases; Dogs; Double-Blind Method; Doxorubicin; Female; Gastrointestinal Diseases; Lymphoma, Non-Hodgkin; Male; Neutropenia; Remission Induction; Survival Analysis; Time Factors | 1998 |
Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
Topics: Adolescent; Adult; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Gastrointestinal Diseases; Germinoma; Hematologic Diseases; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Peripheral Nervous System Diseases; Prognosis; Prospective Studies; Remission Induction; Seminoma; Survival Analysis; Survival Rate; Testicular Neoplasms; Treatment Outcome; Vincristine | 2002 |
4 other study(ies) available for dactinomycin and Cholera Infantum
| Article | Year |
|---|---|
Actinomycin D in the treatment of Paget's disease of bone.
Topics: Aged; Alkaline Phosphatase; Alopecia; Calcium; Dactinomycin; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Osteitis Deformans; Phosphates | 1975 |
Acute and late effects on normal tissues following combined chemo- and radiotherapy for childhood rhabdomyosarcoma and Ewing's sarcoma.
Topics: Antineoplastic Agents; Bone Diseases; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Doxorubicin; Drug Therapy, Combination; Eye Diseases; Gastrointestinal Diseases; Humans; Radiation Injuries; Radiotherapy; Radiotherapy Dosage; Rhabdomyosarcoma; Sarcoma, Ewing; Skin Diseases; Vincristine | 1976 |
Dibromodulcitol (DBD), DTIC, and actinomycin-D in disseminated malignant melanoma. A phase I-II clinical trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dactinomycin; Drug Evaluation; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Male; Melanoma; Middle Aged; Mitolactol | 1985 |
[Medicaments in organ transplantation].
Topics: Adrenal Cortex Hormones; Animals; Bone Marrow Diseases; Dactinomycin; Dogs; Drug Synergism; Gastrointestinal Diseases; Graft vs Host Disease; Graft vs Host Reaction; Humans; Immunosuppressive Agents; Infections; Mercaptopurine; Rabbits; Transplantation, Homologous | 1968 |